𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of metoprolol in dogs with acquired cardiac disease

✍ Scribed by John E. Rush; Lisa M. Freeman; Cari Hiler; Donald J. Brown


Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
463 KB
Volume
4
Category
Article
ISSN
1760-2734

No coin nor oath required. For personal study only.

✦ Synopsis


Objective: To evaluate the response to metoprolol in dogs with dilated cardiomyopathy or endocardiosis receiving standard therapies for management of heart disease.

Background: Beta-blocker therapy has been documented to improve survival in human patients with heart disease and heart failure. There are few studies documenting the effects of beta-blockers in dogs with naturally occurring heart disease.

Methods: A retrospective study of medical records of dogs treated with metoprolol between 1991 and May 2000.

Results: Eighty-seven dogs were treated with metoprolol between 1991 and May 2000. The majority of dogs tolerated the addition of metoprolol in a step-wise fashion. Side effects included syncope, congestive heart failure, lethargy, anorexia, weakness and diarrhea. Side effects were not more likely in dogs with pre-existing congestive heart failure.

Conclusions: Metoprolol was well tolerated in the majority of dogs with naturally occurring dilated cardiomyopathy or endocardiosis. Further studies are required to determine if the administration of metoprolol is beneficial for this patient population.


πŸ“œ SIMILAR VOLUMES


The use of ACE inhibitors in dogs with h
✍ Henrik D. Pedersen; Jens HΓ€ggstrΓΆm; Clarence Kvart πŸ“‚ Article πŸ“… 1999 πŸ› Elsevier Science 🌐 English βš– 132 KB

Journal of Veterinary Cardiology includes two articles dealing with the use of angiotensin-converting enzyme (ACE) inhibitors in small animals. Prompted by that, we would like to take the opportunity to briefly discuss when to use angiotensin-converting enzyme (ACE) inhibitors in the two most common

Use of bioimpedance for measuring cardia
✍ Michael J. DePasquale; Anthony A. Fossa πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 891 KB

Cardiovascular profiling of developmental compounds by General Pharmacology/ Safety Pharmacology is an integral part of the drug discovery process in support of registration of clinical candidates. Non-invasive screening tools which provide hemodynamic measurements can facilitate the drug developmen